RADAR on Drug Benefits

OptumRx Spotlights Two Drugs That Treat Rare Liver Diseases

In OptumRx’s latest Drug Pipeline Report, the UnitedHealth Group-owned PBM highlights a pair of drugs that offer long-sought treatments for two forms of liver disease. Because those diseases are so uncommon, the p...

What Does Full Approval of Pfizer’s COVID-19 Vaccine Mean?

On Aug. 23, the FDA gave full approval to the Pfizer/BioNTech COVID-19 vaccine for people 16 and older. Since last December, nearly 202 million Americans have received at least one dose of a vaccine, including the t...

News Briefs

✦ The FDA approved an additional indication for Jardiance (empagliflozin), allowing the drug to be used to “reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart fai...

Report Quantifies Cost of Utilization Management Wars

Prescription drug utilization management and moves to counteract it introduce billions in costs to payers, providers, manufacturers and consumers alike, a new report suggests. The report, published in the journal He...

Biden Plan to Lower Drug Prices Touts Negotiation, Importation

With President Joe Biden starting to stake out his preferred strategy to lower drug prices, Washington, D.C. insiders say that policies allowing the importation of drugs from Canada and pegging Medicare drug prices ...

Part D Bid Will Drop 11%; Base Premium Will Grow Slightly in 2022

The monthly Medicare Part D base beneficiary premium for 2022 will be $33.37, a slight increase from $33.06 in 2021, according to recent CMS projections. The Part D national average monthly bid amount continued to d...

News Briefs

✦ The HHS Office of Inspector General on Aug. 4 revealed that it will investigate the how the FDA implements its accelerated approval pathway in the wake of the agency approving the controversial Alzheimer’s dru...

Biosimilars Get Call-Out in PBMs’ 2nd Quarter Earnings Calls

Despite experiencing medical cost trends during the second quarter of 2021 that were much less favorable than they were a year ago, publicly traded health insurers during their recent earnings calls were eager to to...

Humana/Anthem PBM Venture Could Attract More Blues Plans

Humana Inc. and Anthem, Inc. are teaming up with hedge fund administrator SS&C Technologies Holdings, Inc. to create DomaniRx, a new joint venture that aims to offer a “best-in-class” PBM cloud-based claims ...

News Briefs

✦ AARP launched a seven-figure, digital ad campaign on July 19 aimed at pressing Congress to support actions to lower drug prices, The Hill reported. The campaign will appear in The New York Times, The Washington ...